Our findings highlight the emerging role of GSDME-mediated EGFR stability in promoting the proliferation of NSCLC cells and provide new insights for the future development of NSCLC therapeutic strategies by targeting GSDME-mediated EGFR stability. Here, GSDME is linked to non-small cell lung carcinoma.